These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16507540)

  • 41. Estrogens in vascular biology and disease: where do we stand today?
    Arnal JF; Scarabin PY; Trémollières F; Laurell H; Gourdy P
    Curr Opin Lipidol; 2007 Oct; 18(5):554-60. PubMed ID: 17885427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of nitric oxide release by nebivolol and its metabolites.
    Maffei A; Vecchione C; Aretini A; Poulet R; Bettarini U; Gentile MT; Cifelli G; Lembo G
    Am J Hypertens; 2006 Jun; 19(6):579-86. PubMed ID: 16733229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biology of atherosclerotic plaques: what we are learning from proteomic analysis.
    Blanco-Colio LM; Martín-Ventura JL; Vivanco F; Michel JB; Meilhac O; Egido J
    Cardiovasc Res; 2006 Oct; 72(1):18-29. PubMed ID: 16814757
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Large-conductance Ca2+-activated K+ currents blocked and impaired by homocysteine in human and rat mesenteric artery smooth muscle cells.
    Cai B; Gong D; Pan Z; Liu Y; Qian H; Zhang Y; Jiao J; Lu Y; Yang B
    Life Sci; 2007 May; 80(22):2060-6. PubMed ID: 17434538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Morpho-functional characteristics of vascular endothelial cells affected by hemodynamic factors].
    Lai X; Liu Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 1997 Mar; 14(1):87-91. PubMed ID: 9817676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification.
    Iyemere VP; Proudfoot D; Weissberg PL; Shanahan CM
    J Intern Med; 2006 Sep; 260(3):192-210. PubMed ID: 16918817
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insights into human hypertension: the role of endothelial dysfunction.
    Giansante C; Fiotti N
    J Hum Hypertens; 2006 Oct; 20(10):725-6. PubMed ID: 16195705
    [No Abstract]   [Full Text] [Related]  

  • 48. Biomarkers of inflammation and endothelial function: the holy grail of experimental and clinical medicine?
    Biasucci LM; Cardillo MT
    Vascul Pharmacol; 2012; 56(1-2):26-8. PubMed ID: 22198643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonclinical safety biomarkers of drug-induced vascular injury: current status and blueprint for the future.
    Mikaelian I; Cameron M; Dalmas DA; Enerson BE; Gonzalez RJ; Guionaud S; Hoffmann PK; King NM; Lawton MP; Scicchitano MS; Smith HW; Thomas RA; Weaver JL; Zabka TS;
    Toxicol Pathol; 2014 Jun; 42(4):635-57. PubMed ID: 24777748
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bibliography. Current word literature. Vascular Biology.
    Curr Opin Hematol; 2003 Mar; 10(2):173-94. PubMed ID: 12613490
    [No Abstract]   [Full Text] [Related]  

  • 51. Endothelial Lessons.
    Vanhoutte PM
    Curr Vasc Pharmacol; 2016; 14(2):175-80. PubMed ID: 26638800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Translation strategy for the qualification of drug-induced vascular injury biomarkers.
    Bendjama K; Guionaud S; Aras G; Arber N; Badimon L; Bamberger U; Bratfalean D; Brott D; David M; Doessegger L; Firat H; Gallas JF; Gautier JC; Hoffmann P; Kraus S; Padro T; Saadoun D; Szczesny P; Thomann P; Vilahur G; Lawton M; Cacoub P
    Toxicol Pathol; 2014 Jun; 42(4):658-71. PubMed ID: 24771082
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autophagy in vascular disease.
    De Meyer GR; Grootaert MO; Michiels CF; Kurdi A; Schrijvers DM; Martinet W
    Circ Res; 2015 Jan; 116(3):468-79. PubMed ID: 25634970
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Circulating endothelial cells: a marker of vascular lesion].
    George F; Sampol J
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):259-61. PubMed ID: 8337140
    [No Abstract]   [Full Text] [Related]  

  • 55. Current status and future directions for diagnostic markers of drug-induced vascular injury.
    Brott DA; Jones HB; Gould S; Valentin JP; Evans G; Richardson RJ; Louden C
    Cancer Biomark; 2005; 1(1):15-28. PubMed ID: 17192029
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Arteriopathia calcificans infantum in an infant with mucoviscidosis].
    Rübe C; Nerlich A; Späth A; Müller-Höcker J
    Pathologe; 1989 Jan; 10(1):53-6. PubMed ID: 2922378
    [No Abstract]   [Full Text] [Related]  

  • 57. ATVB in focus: Smooth muscle cells.
    Gabbiani G; Hansson GK
    Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):379. PubMed ID: 12639829
    [No Abstract]   [Full Text] [Related]  

  • 58. Vascular injury mediated by calcineurin inhibitors: contribution of rheological factors?
    Schut NH
    Kidney Int; 2006 May; 69(10):1915. PubMed ID: 16688195
    [No Abstract]   [Full Text] [Related]  

  • 59. Heterogeneity of vascular endothelial cells in normal and disease states.
    Thorin E; Shreeve SM
    Pharmacol Ther; 1998 Jun; 78(3):155-66. PubMed ID: 9690816
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The investigation of biomarkers in cardiovascular disease: time for a coordinated, international effort.
    Becker RC
    Eur Heart J; 2005 Mar; 26(5):421-2. PubMed ID: 15695531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.